IL132992A0 - Method and compositions for administering taxanes orally to human patients - Google Patents

Method and compositions for administering taxanes orally to human patients

Info

Publication number
IL132992A0
IL132992A0 IL13299298A IL13299298A IL132992A0 IL 132992 A0 IL132992 A0 IL 132992A0 IL 13299298 A IL13299298 A IL 13299298A IL 13299298 A IL13299298 A IL 13299298A IL 132992 A0 IL132992 A0 IL 132992A0
Authority
IL
Israel
Prior art keywords
compositions
human patients
administering taxanes
taxanes orally
orally
Prior art date
Application number
IL13299298A
Other languages
English (en)
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of IL132992A0 publication Critical patent/IL132992A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13299298A 1997-05-27 1998-04-22 Method and compositions for administering taxanes orally to human patients IL132992A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86351397A 1997-05-27 1997-05-27
PCT/US1998/007776 WO1998053811A1 (fr) 1997-05-27 1998-04-22 Methodes et compositions d'administration de taxanes par voie orale a des humains

Publications (1)

Publication Number Publication Date
IL132992A0 true IL132992A0 (en) 2001-03-19

Family

ID=25341241

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13299298A IL132992A0 (en) 1997-05-27 1998-04-22 Method and compositions for administering taxanes orally to human patients
IL132992A IL132992A (en) 1997-05-27 1999-11-17 Preparations for the oral administration of Texans to people

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL132992A IL132992A (en) 1997-05-27 1999-11-17 Preparations for the oral administration of Texans to people

Country Status (23)

Country Link
EP (1) EP0994706B1 (fr)
JP (1) JP2002500667A (fr)
KR (1) KR100615783B1 (fr)
CN (2) CN1550231A (fr)
AR (1) AR012731A1 (fr)
AT (1) ATE308365T1 (fr)
AU (1) AU7130098A (fr)
BR (1) BR9809694A (fr)
CA (1) CA2290446C (fr)
CZ (1) CZ9904244A3 (fr)
DE (1) DE69832173T2 (fr)
DK (1) DK0994706T3 (fr)
ES (1) ES2247690T3 (fr)
HK (1) HK1026637A1 (fr)
HU (1) HUP0003546A3 (fr)
IL (2) IL132992A0 (fr)
NO (1) NO995812L (fr)
PL (1) PL337064A1 (fr)
RU (1) RU2205005C2 (fr)
SK (1) SK157599A3 (fr)
UA (1) UA74767C2 (fr)
WO (1) WO1998053811A1 (fr)
ZA (1) ZA984268B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964946B1 (en) * 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
HUP0002521A3 (en) * 1997-06-20 2002-04-29 Baker Norton Pharma Onium salts of paclitaxel, process for producing them and medicaments comprising the same
GB9718903D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
DE60030283T2 (de) 1999-05-17 2007-09-20 Cancer Research Ventures Ltd. Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen
EP1225956A1 (fr) * 1999-10-27 2002-07-31 Baker Norton Pharmaceuticals, Inc. Methode et compositions pour administration orale de taxanes a des patients humains
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
MXPA03006404A (es) * 2001-01-18 2004-12-02 Upjohn Co Composiciones quimioterapeuticas de microemulsion de paclitaxel con biodisponibilidad oral mejorada.
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
UY27185A1 (es) * 2001-02-28 2002-09-30 Bristol Myers Squibb Co Dosificación metronómica de taxanos
SI1372636T1 (sl) * 2001-02-28 2006-12-31 Bristol Myers Squibb Co Metronomsko odmerjanje taksanov za inhibiranje tumorske rasti
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
GB0523659D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
NZ596868A (en) * 2009-06-02 2014-04-30 Nikan Pharmaceuticals Llc Antagonism of human formyl peptide receptor for treatment of disease
EP4059497A1 (fr) * 2021-03-17 2022-09-21 Dompé farmaceutici S.p.a. C5ar1 inhibiteurs pour le traitement des réactions d'hypersensibilité aux taxanes
CA3212816A1 (fr) * 2021-03-17 2022-09-22 Dompe' Farmaceutici Spa Inhibiteurs de c5ar1 pour le traitement de reactions d'hypersensibilite a des taxanes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
AU665341B2 (en) * 1990-12-18 1996-01-04 Wellcome Foundation Limited, The Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
JP2783680B2 (ja) * 1991-01-11 1998-08-06 ラボラトワール、グラクソ、ソシエテ、アノニム アクリジン誘導体
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
PL187579B1 (pl) * 1994-07-26 2004-08-31 Indena Spa Nowe półsyntetyczne taksany, sposób wytwarzania półsyntetycznych taksanów, nowe związki pośrednie, nowe półsyntetyczne seko-taksany, sposób wytwarzania półsyntetycznych seko-taksanów i przeciwnowotworowe kompozycje farmaceutyczne
TW354293B (en) * 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
CA2224227A1 (fr) * 1995-06-07 1996-12-19 Avmax, Inc. Utilisation d'huiles essentielles pour accroitre la biodisponibilite des composes pharmaceutiques oraux
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
WO1997027855A1 (fr) * 1996-01-31 1997-08-07 Bristol-Myers Squibb Company Procede permettant de rendre actifs du point de vue pharmaceutique des taxanes assimilables par voie orale
WO1997048689A1 (fr) * 1996-06-17 1997-12-24 Eli Lilly And Company Modulateurs de la resistance aux medicaments et de la resistance multiple aux medicaments
GB9718903D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
CA2326485C (fr) * 1998-04-01 2008-12-09 Rtp Pharma Inc. Compositions anticancereuses

Also Published As

Publication number Publication date
EP0994706B1 (fr) 2005-11-02
CZ9904244A3 (cs) 2001-10-17
NO995812L (no) 2000-01-25
KR100615783B1 (ko) 2006-08-25
NO995812D0 (no) 1999-11-26
ATE308365T1 (de) 2005-11-15
ES2247690T3 (es) 2006-03-01
ZA984268B (en) 1999-06-23
SK157599A3 (en) 2002-10-08
CN1550231A (zh) 2004-12-01
DE69832173T2 (de) 2006-08-03
CA2290446A1 (fr) 1998-12-03
AU7130098A (en) 1998-12-30
HUP0003546A3 (en) 2002-12-28
PL337064A1 (en) 2000-07-31
EP0994706A1 (fr) 2000-04-26
HUP0003546A2 (hu) 2002-11-28
BR9809694A (pt) 2000-10-03
IL132992A (en) 2006-08-20
UA74767C2 (en) 2006-02-15
CN1261275A (zh) 2000-07-26
DE69832173D1 (de) 2005-12-08
EP0994706A4 (fr) 2001-05-16
RU2205005C2 (ru) 2003-05-27
CA2290446C (fr) 2008-01-29
AR012731A1 (es) 2000-11-08
JP2002500667A (ja) 2002-01-08
DK0994706T3 (da) 2006-03-06
HK1026637A1 (en) 2000-12-22
WO1998053811A1 (fr) 1998-12-03
KR20010013025A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
PL341592A1 (en) Method of administering human aspb28 insulin
HUP0300836A3 (en) Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
IL135951A0 (en) Antimutagenic compositions for the treatment and prevention of photodamage to skin
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
IL118637A (en) Oral pharmaceutical compositions of s(+)-ibuprofen
AU2001249329A1 (en) Lipoxin analogs and methods for the treatment of periodontal disease
EP1129217A4 (fr) Compositions et methodes permettant de diagnostiquer et de traiter des maladies
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
IL132992A0 (en) Method and compositions for administering taxanes orally to human patients
HUP0004096A3 (en) Aggregates of human insulin derivatives and pharmaceutical compositions comprising thereof
HK1035146A1 (en) Pharmaceutical composition for use in emergency treatment and preparation method thereof
PL341230A1 (en) Solid dosage forms of ribavirin for oral administration and method of obtaining them
IL118636A (en) Oral pharmaceutical compositions of S(+)-etodolac
IL149360A0 (en) Method and compositions for administering taxanes orally to human patients
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
EP1181022A4 (fr) Compositions medicinales et leur procede de preparation
EP1210075A4 (fr) Compositions et methodes pour modifier le taux de lipides cutanes
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
IL118525A0 (en) Oral pharmaceutical composition of piperidinoalkanOral pharmaceutical composition of piperidinoalkanol compounds in solution form ol compounds in solution form
AU784159C (en) Method and compositions for administering taxanes orally to human patients
HU9801869D0 (en) Pharmaceutical composition for enhancing level of l-carnitin in human patients
AU1621501A (en) Methods and compositions for treatment of disease
AU4491697A (en) Compositions of therapeutic agents suitable for oral administration

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed